VEGFA and age-related macular degeneration: reported that CDs functionalized with the anti‐VEGF agents show elevated penetration of the eye structure, and their strong fluorescence is beneficial to noninvasive intraocular concentration monitoring.[202] Furthermore, due to the inhibitory functions in the formation of choroidal blood vessels, the anti‐VEGF‐modified CDs are versatile in the application of fundus neovascular diseases, such as AMD and DR.